Does preoperative total parenteral nutrition in patients with ulcerative colitis produce better outcomes?
Harry M. Salinas(Baptist Hospital of Miami), Liliana Bordeianou(Massachusetts General Hospital), Richard Hodin(Massachusetts General Hospital), Deanna D. Nguyen, Paul C. Shellito(Harvard University), A Dursun(Massachusetts General Hospital), Ioannis T. Konstantinidis(Massachusetts General Hospital)
Cited by 39
Related Papers
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
|Journal of Clinical Oncology|2009|507
Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients
|Journal of Clinical Oncology|2005|419
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
|Clinical Cancer Research|2021|369
Automated detection of retinal layer structures on optical coherence tomography images
|Optics Express|2005|293